Mechanisms of cell cycle arrest in response to TGF-β in progestin- dependent and -independent growth of mammary tumors

Experimental Cell Research

Volumn 265, Issue 1, 2001, Pages 152-166

  Salatino, Mariana ^a   Labriola, Leticia ^a   Schillaci, Roxana ^a   Charreau, Eduardo H ^a,b   Elizalde, Patricia V ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Cell cycle; Mammary tumors; Progestins; Transforming growth factor (TGF )

Indexed keywords

CYCLIN A; CYCLIN D1; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR; PROTEIN P21; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035870130     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5175     Document Type: Article

References (61)

1. The transforming growth factor βs
2. Molecular mechanisms of transforming growth factor β signaling
3. Mechanism of activation of TGF-β receptor
4. SMADS: Mediators and regulators of TGF-β signaling
5. The retinoblastoma protein and cell cycle control
6. Cyclins and breast cancer
7. Negative regulation of cell growth by TGF-β
8. Production and responsiveness to transforming growth factor-β in normal and oncogene-transformed human mammary epithelial cells
9. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells
10. Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines
11. Transforming growth factor β: A potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells
12. Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines
13. Effects of TGF-β on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells
14. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential
15. Transforming growth factor-β activities in "in vivo" lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
16. Correlation of TGF-β1 expression with medroxyprogesterone acetate responsiveness in mouse mammary adenocarcinomas
17. Differential expression of and responsiveness to transforming growth factor β (TGF-β) isoforms in hormone-dependent and independent lines of mouse mammary tumors
18. Mouse mammary tumors induced by medroxyprogesterone acetate: Immunohistochemistry and hormonal receptors
19. Mammary adenocarcinomas induced by medroxyprogesterone acetate: Hormone dependence and EGF receptors of BALB/c in vivo sublines
20. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma
21. Characterization of the murine cyclin D2 gene: Exon/intron organization and promoter activity
22. KIP1
23. Redundant cyclin overexpression and gene amplification in breast cancer cells
24. Cyclin E, a redundant cyclin in breast cancer
25. Processing of cyclin E differs between normal and tumor breast cells
26. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells
27. Phosphorylation of human progesterone receptor by cyclin dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo
28. TGF-β1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expression
29. Inhibition of cell growth by TGF-β1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells
30. Kip1
31. INK4B cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells
32. Physical interaction of the retinoblastoma protein with human D cyclins
33. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
34. D-type cyclin-dependent kinase activity in mammalian cells
35. TGF-β inhibition of cdk4 synthesis is linked to cell cycle arrest
36. p53 dependent repression of cdk4 translation in TGF-β-induced cell cycle arrest
37. INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells
38. Kip/Cip and Ink4 inhibitors cooperate to induce cell cycle arrest in response to TGF-β
39. INK4B is a potential effector of TGF-β induced cell cycle arrest
40. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases
41. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells
42. RNA fingerprint using arbitrarily primed PCR identifies differentially regulated RNAs in mink lung (My1Lu) cells growth arrested by transforming growth factor β1
43. Down-regulation of the cyclin A promoter by transforming growth factor-β1 is associated with a reduction in phosphorylated activating transcription factor-1 and cyclin AMP-responsive element-binding protein
44. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism
45. Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect
46. Transforming growth factor β1 can induce CIP1/WAF! expression independent of the p53 pathway in ovarian cancer cells
47. TGF-βinduced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression
48. Insensitivity to growth inhibition by TGF-β1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells
49. Transforming growth factor β1 upregulates p15, p21 and p27 and blocks cell cyclin in G1 in human prostate epithelium
50. Rapid induction of p21 WAF1 but delayed down-regulation of Cdc25A in the TGF-β-induced cell cycle arrest of gastric carcinoma cells
51. Cell cycle arrest in G0/G1 phase by contact inhibition and TGF-β1 in mink Mv1Lu lung epithelial cells
52. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types
53. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-cdk complexes
54. Steroid hormone receptors and their regulation by phosphorylation
55. Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas
56. Differential phosphorylation of chicken progesterone receptor in hormone-dependent and ligand-independent activation
57. Involvement of insulin-like growth factors I and II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas
58. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas
59. KIP1 a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
60. INK4B induction and growth inhibition in astrocytes is Smad3-dependent and a pathway prominently altered in human glioma cell line
61. WAF1/CIP1 in human breast cancer